Technical Specifications Compound: Glycyl-L-Histidyl-L-Lysine Copper Complex (GHK-Cu) Format: Lyophilized peptide Strength: 50 mg per vial Purity: 9899% (COA included) Appearance: Blue-hued lyophilized powder Category: Research reagent (non-clinical) Intended Use This product is intended exclusively for: Laboratory research In-vitro experimentation Biochemical and molecular assays Mechanistic pathway studies Preclinical, non-human model exploration Institutional or academic research programs Not intended for: Human or veterinary consumption Cosmetic or dermatological use Injection, ingestion, inhalation, or topical use Medical, therapeutic, or clinical applications This material is not approved by Health Canada, FDA, or any regulatory authority for clinical use
Why Im Not Using Experimental Peptide Treatments Insufficient evidence
Results vary depending on the goal: Skin texture and hydration: Often visible within 24 weeks
What the Market Looks Like After Amino Asylum, Paradigm Peptides, and Peptide Sciences The post-shutdown research peptide market of 2026 is structurally different from 2024
Rights and permissions About this article Cite this article Ghosh, S., Saha, S., Mondal, S